The study of NK cells in middle-aged TKI-treated CML patients shows that the percentage of CD56bright NK cells is similar to the percentage found in heathy middle-aged individuals, whereas the minor population of CD56dim NK cells co-expressing CD11b and CD27 is dramatically decreased (Figure 6B). This evidence concerns the gene ITGAM and chronic myelogenous leukemia, BCR-ABL1 positive.